Literature DB >> 24011238

Diagnosis and epidemiology of Helicobacter pylori infection.

Xavier Calvet1, María-José Ramírez Lázaro, Philippe Lehours, Francis Mégraud.   

Abstract

A limited amount of new information was published in the field of diagnosis and epidemiology of Helicobacter pylori this last year. Besides some improvement in current tests, it is interesting to note the attempts to identify severe disease, for example gastric cancer, by breath analysis using nanomaterial-based sensors. In contrast, the predictive value for gastric cancer and atrophy of pepsinogen determinations was found inadequate. Prevalence studies of H. pylori infection have been carried out in adults and children around the world in the general population but also in specific communities. The usual risk factors were found. In addition, a Japanese study highlighted the role of grandmothers in the familial transmission of H. pylori. A study showed that the infection may not always readily establish itself in children, given the number of transient infections observed. It was also noted that after eradication, a first-year relapse is likely to be a recurrence of the previous infection, while later on it is probably a reinfection with a new strain.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Invasive tests; SAT; UBT; pepsinogen; prevalence; relapse; transmission

Mesh:

Year:  2013        PMID: 24011238     DOI: 10.1111/hel.12071

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  48 in total

Review 1.  Nontraditional therapies to treat Helicobacter pylori infection.

Authors:  Morris O Makobongo; Jeremy J Gilbreath; D Scott Merrell
Journal:  J Microbiol       Date:  2014-03-29       Impact factor: 3.422

2.  High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patients.

Authors:  Laimas Jonaitis; Gediminas Kiudelis; Paulius Slepavicius; Limas Kupcinskas
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

3.  N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.

Authors:  Luís Eduardo S Fontes; Ana Luiza C Martimbianco; Carolina Zanin; Rachel Riera
Journal:  Cochrane Database Syst Rev       Date:  2019-02-12

4.  Association of Helicobacter pylori and Crohn's Disease Incidence: An Inversion Reaction?

Authors:  Lars Erik Bartels; Jens Frederik Dahlerup
Journal:  Dig Dis Sci       Date:  2017-04-05       Impact factor: 3.199

Review 5.  Role of Helicobacter pylori infection in autoimmune systemic rheumatic diseases.

Authors:  Mislav Radić
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 6.  Meta-analysis: is combination of tetracycline and amoxicillin suitable for Helicobacter pylori infection?

Authors:  Zhi-Fa Lv; Fu-Cai Wang; Hui-Lie Zheng; Ben Wang; Yong Xie; Xiao-Jiang Zhou; Nong-Hua Lv
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

7.  Helicobacter pylori Does not Affect Postoperative Outcomes After Sleeve Gastrectomy.

Authors:  Hiba Shanti; Neyaf Almajali; Tamador Al-Shamaileh; Walid Samarah; Ayman Mismar; Firas Obeidat
Journal:  Obes Surg       Date:  2017-05       Impact factor: 4.129

Review 8.  Characteristics of gastric cancer in Asia.

Authors:  Rubayat Rahman; Akwi W Asombang; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

9.  Virulence genes of Helicobacter pylori in the Dominican Republic.

Authors:  Seiji Shiota; Modesto Cruz; José A Jiménez Abreu; Takahiro Mitsui; Hideo Terao; Mildre Disla; Shun Iwatani; Hiroyuki Nagashima; Miyuki Matsuda; Tomohisa Uchida; Lourdes Tronilo; Eduardo Rodríguez; Yoshio Yamaoka
Journal:  J Med Microbiol       Date:  2014-06-25       Impact factor: 2.472

Review 10.  Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori.

Authors:  Oren Cohen; Garrett Locketz; Alon Y Hershko; Alexander Gorshtein; Yair Levy
Journal:  Rheumatol Int       Date:  2015-07-26       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.